Cassava Sciences, Inc.(SAVA)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Snapshot
$2.34
52-Week Range
$1.75 – $4.98
YTD
+12.15%
IV Rank (30D)
24.1
Straddle Price
$1.33
P/C Vol Ratio
1.84
Market Cap
$0.1B
Fair Value

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 0.5% and dividend payments are stable.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.00%
Beta vs SPY1.00
Cost of Equity (CAPM)9.50% (VRP-adj)
WACC9.50%
Volatility Risk Premium+115.0pp (IV − HV30), ERP adj +50bps
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+3.0%
DCF Horizon5 years explicit + fade
Forward Tilt (NTM/TTM)×1.03 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$-0.0B
Return on Equity (TTM)-122.3%
Book / Price65.6% — banking bias active (P/B is primary)
Debt / Equity0.00
Quality Score1/6 — cyclical/struggling (5y DCF)
SMA 50$2.14 (Market Anchor value)
SMA 20 / Bollinger Mid$2.24
Bollinger Width / SMA20954.9% (drives anchor stability)
Net Debt$-0.1B
Market Cap$0B
Blended Fair Value
Current Price
$2.34
Deviation
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0%
Peer EV/EBITDA n/a 0%
Peer P/B n/a 0%
Peer P/S n/a 0%
Market Anchor (SMA50) $2.14 0% stability 0% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-06-01 · updated 2026-06-01 09:30:57.386000
Info
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834)
Exchange
XNAS
Market Cap
$0.1B

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufil…

Price History
Seasonality
MonthAvg ReturnYears of Data
Jan +28.87% 7
Feb +14.81% 7
Mar -12.81% 8
Apr +7.37% 7
May +2.13% 7
Jun +8.27% 7
Jul +9.97% 7
Aug +4.81% 7
Sep +53.27% 7
Oct -5.82% 7
Nov -8.73% 7
Dec +19.96% 7
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $2.24
SMA 50: $2.14
SMA 200: $2.52
Current: $2.34
EMA 12: $2.27
EMA 26: $2.23
MACD: 0.0423 | Signal: 0.0175
BULLISH
ADX (14): 22.74
WEAK TREND
+DI: 33.62
−DI: 17.11
Momentum Oscillators
RSI (14): 56.38
NEUTRAL
Stoch %K: 72.43
Stoch %D: 73.19
Williams %R: -27.57
Volume & Volatility
BB Upper: $2.47
BB Lower: $2.00
NEUTRAL
OBV: -133,915,435
Vol SMA 20: 646,873
Vol ROC: -100.00%
ATR: $0.12
True Range: $0.00
HV 20: 81.1%
HV 30: 74.1%
HV 60: 90.3%

Data Summary
Data Points: 500
Last Updated: 2026-06-12T21:15:26.139000
Date Range: 2024-03-18T00:00:00 – 2026-03-16T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
Earnings History
8 of 8 under expected move
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2024-08-08 Pre-Market 28.07% 10.75% 0.38x Within
2024-11-07 Pre-Market 12.31% 5.74% 0.47x Within
2025-01-07 Pre-Market 9.11% 0.03% 0.00x Within
2025-03-03 Pre-Market 11.39% 0.46% 0.04x Within
2025-05-08 Pre-Market 11.73% 9.95% 0.85x Within
2025-08-14 After-Close 4.58% 2.50% 0.55x Within
2025-11-12 After-Close 16.41% 9.82% 0.60x Within
2026-03-12 Pre-Market 18.13% 0.00% 0.00x Within
Options Activity
IV Rank (30D)
24.1
IV Rank (7D)
24.1
Avg IV
217.6%
Straddle (30D)
$1.33
Straddle (7D)
$1.33
P/C Volume
1.84
Spread Scanner GPU

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Volatility Surface

Enter a ticker to render the implied volatility surface.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
2.08
Correlation (SPY)
23.8%
0.06
Ann. Volatility
98.2%
SPY Volatility
11.2%

High volatility - stock moves more than market

Beta & Alpha Over Time
Institutional Ownership (13F)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

# Filer Shares Value % of Total % of Float Period
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period
Insider Activity
Latest: 2025-11-25
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2025-11-25 Robert Eugene Jr Anderson Director Buy (P) +8,600 $2.90 $24.9K EDGAR
2025-11-24 Richard Barry President & CEO Buy (P) +150,000 $2.76 $414.0K EDGAR
2025-11-20 Richard Barry President & CEO Buy (P) +73,385 $2.75 $201.8K EDGAR
2025-10-22 Dawn Carter Bir Director Grant (A) +53,000 opt EDGAR
2025-10-02 Robert Christopher Cook Chief Operating & Legal Office Buy (P) +13,725 $2.91 $39.9K EDGAR
2025-09-23 Richard Barry President & CEO Buy (P) +7,172 $2.28 $16.4K EDGAR
2025-09-22 Richard Barry President & CEO Buy (P) +237,941 $2.25 $534.7K EDGAR
2025-07-16 PATRICK J MD PHD SCANNON Director Grant (A) +26,500 opt EDGAR
2025-05-27 Claude Nicaise Director Grant (A) +26,500 opt EDGAR
2025-05-27 Pierre Gravier Director Grant (A) +26,500 opt EDGAR
2025-05-27 Robert Eugene Jr Anderson Director Grant (A) +26,500 opt EDGAR
2025-05-27 ROBERT Z GUSSIN Director Grant (A) +26,500 opt EDGAR
2025-05-27 DONNELL MICHAEL J O Director Grant (A) +26,500 opt EDGAR
2025-04-21 Richard Barry President & CEO Grant (A) +350,000 opt EDGAR
2025-04-21 Eric Schoen Chief Financial Officer Grant (A) +100,000 opt EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
10 insiders · @ $2.34
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 REMI BARBIER President & CEO 1,162,854 $2.73M $699.0K 13 2024-05-22
2 SANFORD ROBERTSON Director 955,851 $2.24M $5.48M 15 2024-05-16
3 Richard Barry President & CEO 938,060 $2.20M $4.63M 11 2025-11-24
4 NADAV FRIEDMANN Chief Medical Officer 80,053 $187.6K $0 4 2022-10-03
5 Robert Christopher Cook Chief Operating & Legal Office 13,725 $32.2K $39.9K 6 2025-10-02
6 Eric Schoen Chief Financial Officer 11,500 $27.0K -$83.6K 9 2025-04-21
7 ROBERT Z GUSSIN Director 10,617 $24.9K $0 8 2025-05-27
8 DONNELL MICHAEL J O Director 9,651 $22.6K $0 6 2025-05-27
9 Robert Eugene Jr Anderson Director 8,600 $20.2K $24.9K 4 2025-11-25
10 PATRICK J MD PHD SCANNON Director 1,000 $2.3K $0 6 2025-07-16
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

TTM Net Income$-0.1B
TTM EPS$-1.88